Company Overview of Biohealth Innovation
Key Executives for Biohealth Innovation
Chief Executive Officer and President
Compensation as of Fiscal Year 2017.
Biohealth Innovation Key Developments
BioHealth Innovation, Inc. Wins Renewal of its Contract to Extend and Expand its Entrepreneur-In-Residence Program with the National Institutes of Health
Apr 10 17
BioHealth Innovation Inc. has been awarded a renewal of its contract to extend and expand its entrepreneur-in-residence (EIR) program with the National Institutes of Health (NIH). BHI will place EIRs within the National Heart, Lung and Blood Institute (NHLBI), the NIH Office of the Director and other NIH Institutes and Centers. Due to the program's initial success, the EIR program was expanded in 2015 to include NIH's associated offices and institutes. The new term extends for an 18-month period from February 2017 through August 2018, with an option to renew for an additional 18 months. BHI can retain the services of up to six EIRs as a part of this program with NIH. The EIRs will be assigned to the appropriate facilities, and their task will be to foster collaboration between NIH leadership and the bio-health industry, while providing the agency with industry insights into innovation and commercialization perspectives in research and development. They will also help to guide NIH scientists, academics and small business innovators on best practices.
Maryland Economic Development Corporation Partners with Biohealth Innovation, Inc. to Manage Germantown Innovation Center
Oct 24 16
BioHealth Innovation Inc. announced that the Maryland Economic Development Corporation (MEDCO) has selected BHI to manage the Germantown Innovation Center (GIC) located within the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). Additionally, BHI and PIC MC have signed an agreement to work collaboratively on business incubation and company recruitment at the PIC MC—a 20-acre integrated academic, business and research campus. BHI will lead the overall management, programming, and entrepreneurial support at the GIC, which includes new company recruitment to the facility. BHI will use its network of partnerships with leading biohealth industry organizations and regional service providers to support the budding small businesses at the GIC for individual growth needs. Additionally, BHI and Montgomery College will host outreach events with the overall goal of building a stronger biohealth community.
BioHealth Innovation, Inc. Announces Board Appointments
Aug 2 16
BioHealth Innovation Inc. announced that its Board of Directors has voted and approved the appointments of new board members William Hearl, Founder and CEO of Immunomic Therapeutics Inc. and Founder of Capital Genomix Inc., and Lily Qi, M.B.A., Assistant Chief Administrative Officer for Economic and Workforce Development, Office of the County Executive for Montgomery County, Maryland. Dr. Hearl's leadership and expertise in immunotherapies have aided ITI in the development of LAMP-vax, a technology that would allow the use of nucleic acid immunotherapies to broaden the potential uses of cancer immunotherapies. Ms. Qi grew up in Shanghai and became the first political appointee from China in the State of Maryland.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries